Shandong Boan Biotechnology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Shandong Boan Biotechnology Co., Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 8.09% vs 15.30% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -90.30% vs 160.20% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "851.20",
          "val2": "787.50",
          "chgp": "8.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "130.70",
          "val2": "145.30",
          "chgp": "-10.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "41.90",
          "val2": "35.40",
          "chgp": "18.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.70",
          "val2": "79.40",
          "chgp": "-90.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "41.70%",
          "val2": "84.10%",
          "chgp": "-4.24%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

851.20

787.50

8.09%

Operating Profit (PBDIT) excl Other Income

130.70

145.30

-10.05%

Interest

41.90

35.40

18.36%

Exceptional Items

0.40

0.00

Consolidate Net Profit

7.70

79.40

-90.30%

Operating Profit Margin (Excl OI)

41.70%

84.10%

-4.24%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 8.09% vs 15.30% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -90.30% vs 160.20% in Dec 2024

All Annual Results